Surgery Partners, Inc., through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and a suite of ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 12, 2018, the company operated approximately 180 locations in 32 states, including ambulatory surgery centers, surgical hospitals, a diagnostic laboratory, multi-specialty physician practices, and urgent care facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SGRY
Previous Symbol
CUSIPN/A
Phone615-234-5900
Debt
Debt-to-Equity Ratio1.72
Current Ratio1.57
Quick Ratio1.42
Price-To-Earnings
Trailing P/E Ratio-14.90
Forward P/E Ratio-16.69
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.34 billion
Price / Sales0.46
Cash Flow$0.3033 per share
Price / Cash Flow41.28
Book Value$27.41 per share
Price / Book0.46
Profitability
EPS (Most Recent Fiscal Year)($0.84)
Net Income$-52,980,000.00
Net Margins-5.55%
Return on Equity-1.68%
Return on Assets-0.47%
Miscellaneous
Employees10,600
Outstanding Shares48,890,000
Market Cap$649.28 million
OptionableOptionable
Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions
What is Surgery Partners' stock symbol?
Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."
How will Surgery Partners' stock buyback program work?
Surgery Partners announced that its board has approved a stock buyback program on Saturday, December 16th 2017, which authorizes the company to repurchase $50,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company's management believes its stock is undervalued.
How were Surgery Partners' earnings last quarter?
Surgery Partners Inc (NASDAQ:SGRY) posted its quarterly earnings results on Wednesday, November, 7th. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.18) by $0.01. The firm earned $443.90 million during the quarter, compared to the consensus estimate of $440.38 million. Surgery Partners had a negative return on equity of 1.68% and a negative net margin of 5.55%. The firm's revenue was up 44.9% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.02) earnings per share. View Surgery Partners' Earnings History.
When is Surgery Partners' next earnings date?
What guidance has Surgery Partners issued on next quarter's earnings?
Surgery Partners issued an update on its FY 2018 earnings guidance on Wednesday, November, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.75-1.8 billion, compared to the consensus revenue estimate of $1.78 billion.
What price target have analysts set for SGRY?
7 analysts have issued twelve-month price objectives for Surgery Partners' stock. Their forecasts range from $15.00 to $25.00. On average, they anticipate Surgery Partners' share price to reach $18.6667 in the next year. This suggests a possible upside of 49.1% from the stock's current price. View Analyst Price Targets for Surgery Partners.
What is the consensus analysts' recommendation for Surgery Partners?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Surgery Partners.
Has Surgery Partners been receiving favorable news coverage?
News coverage about SGRY stock has trended somewhat positive on Saturday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Surgery Partners earned a coverage optimism score of 1.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the next few days.
Who are some of Surgery Partners' key competitors?
Who are Surgery Partners' key executives?
Surgery Partners' management team includes the folowing people:
- Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 47)
- Mr. Dennis Dean, Exec. Officer (Age 46)
- Mr. Clifford G. Adlerz, Consultant & Director (Age 64)
- Mr. Wayne Scott DeVeydt, CEO & Director (Age 48)
- Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 46)
Who are Surgery Partners' major shareholders?
Surgery Partners' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include NN Investment Partners Holdings N.V. (11.45%), Clearbridge Investments LLC (6.65%), Vanguard Group Inc. (3.20%), Vanguard Group Inc (3.20%), BlackRock Inc. (2.54%) and Elk Creek Partners LLC (2.26%). Company insiders that own Surgery Partners stock include Brandan Lingle and HIG Surgery Centers, Llc. View Institutional Ownership Trends for Surgery Partners.
Which institutional investors are selling Surgery Partners stock?
SGRY stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, BlackRock Inc., JPMorgan Chase & Co., JPMorgan Chase & Co., Bank of New York Mellon Corp, Dimensional Fund Advisors LP, Strs Ohio and TIAA CREF Investment Management LLC. View Insider Buying and Selling for Surgery Partners.
Which institutional investors are buying Surgery Partners stock?
SGRY stock was bought by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd., Renaissance Technologies LLC, Clearbridge Investments LLC, Highland Capital Management LP, Citadel Advisors LLC, AMI Asset Management Corp, NN Investment Partners Holdings N.V. and GSA Capital Partners LLP. View Insider Buying and Selling for Surgery Partners.
How do I buy shares of Surgery Partners?
Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Surgery Partners' stock price today?
One share of SGRY stock can currently be purchased for approximately $12.52.
How big of a company is Surgery Partners?
Surgery Partners has a market capitalization of $649.28 million and generates $1.34 billion in revenue each year. The company earns $-52,980,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Surgery Partners employs 10,600 workers across the globe.
What is Surgery Partners' official website?
How can I contact Surgery Partners?
Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]
MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
